Omarigliptin Improves Glycemic Control and Is Well Tolerated as Add-on Therapy to Oral Antihyperglycemic Agents in Japanese Patients with Type 2 Diabetes

被引：0
|
作者：
Gantz, Ira
Okamoto, Taro
Sato, Asako
Okuyama, Kotoba
Lai, Eseng
Engel, Samuel S.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1231-P
引用
收藏
页码：A318 / A319
页数：2
相关论文
共 50 条
  • [31] Combination therapy with insulin and oral agents:: optimizing glycemic control in patients with type 2 diabetes mellitus
    Yki-Järvinen, H
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 : S77 - S81
  • [32] Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy
    Kadowaki T.
    Tajima N.
    Odawara M.
    Minamide T.
    Kawashima M.
    Yanagida D.
    Okamoto T.
    Arjona Ferreira J.C.
    Diabetology International, 2013, 4 (3) : 160 - 172
  • [33] Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
    von Websky, Karoline
    Reichetzeder, Christoph
    Hocher, Berthold
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 681 - 694
  • [34] Sitagliptin Add-On to Metformin plus Sulphonylurea Combination Therapy: The Efficacy of Triple Therapy on Glycemic Control in Type 2 Diabetes
    Sargin, Mehmet
    Tekin, Sakin
    Can, Ozgur
    Kisioglu, Savas Volkan
    Tekin, Buket Vatansever
    Orbay, Ekrem
    Tekce, Mustafa
    Aliustaoglu, Mehmet
    DIABETES, 2013, 62 : A669 - A670
  • [35] Exenatide monotherapy improves glycemic control and is well tolerated over 24 weeks in drug-naive patients with type 2 diabetes
    Brodows, Robert
    Milton, Denai
    Ridge, Terry D.
    Macconell, Leigh
    Okerson, Ted
    Wolka, Anne M.
    Moretto, Thomas J.
    DIABETES, 2008, 57 : A145 - A145
  • [36] Oral insulin spray as an add-on therapy in combination with failing oral agents (OHAs) for treatment of type-2 diabetes
    Guevara-Aguirre, J
    Guevara, M
    Saavedra, J
    Baldeon, G
    Moncayo, P
    Llore, L
    Cando, A
    Modi, P
    DIABETES, 2002, 51 : A99 - A99
  • [37] Exubera® is well tolerated and achieves tight glycemic control in patients with type 1 diabetes
    Dumas, R
    England, RD
    Riese, RJ
    Teeter, JG
    DIABETES, 2005, 54 : A87 - A87
  • [38] EFFECTS OF METFORMIN OR ACARBOSE AS ADD-ON TO INSULIN THERAPY ON GLYCEMIC VARIABILITY IN TYPE 2 DIABETES
    Lu, J.
    Xiaojing, M.
    Lei, Z.
    Yifei, M.
    Lingwen, Y.
    Wei, L.
    Wei, Z.
    Yuqian, B.
    Jian, Z.
    Weiping, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A61 - A62
  • [39] Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics
    Osonoi, Takeshi
    Nakamoto, Shinya
    Saito, Miyoko
    Tamasawa, Atsuko
    Ishida, Hidenori
    Osonoi, Yusuke
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02) : 341 - 353
  • [40] Luseogliflozin, a SGLT2 inhibitor, as add-on therapy to 5 types of oral antidiabetic drugs improves glycaemic control and reduces body weight in Japanese patients with type 2 diabetes mellitus
    Haneda, M.
    Seino, Y.
    Sasaki, T.
    Fukatsu, A.
    Ubukata, M.
    Sato, Y.
    Sakai, S.
    Samukawa, Y.
    DIABETOLOGIA, 2013, 56 : S384 - S384
12345